Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q3 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.